Mithra Pharmaceuticals (CHIX:MITRAB) Short-Term Capital Lease Obligation : €6.23 Mil (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals Short-Term Capital Lease Obligation?

Mithra Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was €6.23 Mil.

Mithra Pharmaceuticals's quarterly Short-Term Capital Lease Obligation declined from Jun. 2022 (€6.18 Mil) to Dec. 2022 (€5.18 Mil) but then increased from Dec. 2022 (€5.18 Mil) to Jun. 2023 (€6.23 Mil).

Mithra Pharmaceuticals's annual Short-Term Capital Lease Obligation declined from Dec. 2020 (€7.32 Mil) to Dec. 2021 (€6.56 Mil) and declined from Dec. 2021 (€6.56 Mil) to Dec. 2022 (€5.18 Mil).

Mithra Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Mithra Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Short-Term Capital Lease Obligation Chart

Mithra Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.14

6.75

7.32

6.56

5.18

Mithra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															6.16	6.56	6.18	5.18	6.23

Mithra Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Mithra Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Mithra Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mithra Pharmaceuticals (CHIX:MITRAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (CHIX:MITRAb) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

0R91:UK 1TM:Germany MITRA:Belgium

Address

Rue Saint-Georges 5, Liege, BEL, 4000

Website

https://www.mithra.com

Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (CHIX:MITRAB) Headlines

No Headlines